0001062993-22-024501.txt : 20221227
0001062993-22-024501.hdr.sgml : 20221227
20221227191720
ACCESSION NUMBER: 0001062993-22-024501
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221222
FILED AS OF DATE: 20221227
DATE AS OF CHANGE: 20221227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heffernan Michael Thomas
CENTRAL INDEX KEY: 0001448914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 221491432
MAIL ADDRESS:
STREET 1: C/O CORNERSTONE THERAPEUTICS INC.
STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250
CITY: CARY
STATE: NC
ZIP: 27518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-12-22
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001448914
Heffernan Michael Thomas
C/O COLLEGIUM PHARMACEUTICAL, INC.
100 TECHNOLOGY CENTER DRIVE
STOUGHTON
MA
02072
1
0
0
0
Common Stock
2022-12-22
4
M
0
237
16.150
A
28260
D
Common Stock
2022-12-22
4
S
0
237
23.0
D
28023
D
Common Stock
2022-12-23
4
M
0
4989
16.150
A
33012
D
Common Stock
2022-12-23
4
S
0
4989
23.0
D
28023
D
Common Stock
2022-12-27
4
M
0
15995
16.150
A
44018
D
Common Stock
2022-12-27
4
S
0
15995
23.63
D
28023
D
Common Stock
2022-12-27
4
M
0
3820
16.150
A
31843
D
Common Stock
2022-12-27
4
S
0
3820
24.16
D
28023
D
Stock Option (Right to Purchase)
16.150
2022-12-22
4
M
0
237
0
D
2026-01-20
Common Stock
237
24804
D
Stock Option (Right to Purchase)
16.150
2022-12-23
4
M
0
4989
0
D
2026-01-20
Common Stock
4989
19815
D
Stock Option (Right to Purchase)
16.150
2022-12-27
4
M
0
15995
0
D
2026-01-20
Common Stock
15995
3820
D
Stock Option (Right to Purchase)
16.150
2022-12-27
4
M
0
3820
0
D
2026-01-20
Common Stock
3820
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).
The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.
/s/ Colleen Tupper as Attorney-In-Fact For Michael T. Heffernan
2022-12-27